GB0424564D0 - Organic compounds - Google Patents
Organic compoundsInfo
- Publication number
- GB0424564D0 GB0424564D0 GB0424564A GB0424564A GB0424564D0 GB 0424564 D0 GB0424564 D0 GB 0424564D0 GB 0424564 A GB0424564 A GB 0424564A GB 0424564 A GB0424564 A GB 0424564A GB 0424564 D0 GB0424564 D0 GB 0424564D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- organic compounds
- compounds
- organic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0424564A GB0424564D0 (en) | 2004-11-05 | 2004-11-05 | Organic compounds |
EP09167139A EP2135609A1 (en) | 2004-11-05 | 2005-11-03 | Combinations of nicotinic acetylcholine alpha 7 receptor agonists |
EP20110155176 EP2332537A1 (en) | 2004-11-05 | 2005-11-03 | Combinations of nicotinic acetylcholine alpha 7 receptor agonists |
CA2582436A CA2582436C (en) | 2004-11-05 | 2005-11-03 | Combinations of nicotinic acetylcholine alpha 7 receptor agonists |
US11/718,668 US20080306081A1 (en) | 2004-11-05 | 2005-11-03 | Combinations of Nicotinic Acetylcholine Alpha 7 Receptor Antagonists |
RU2007120690/15A RU2007120690A (ru) | 2004-11-05 | 2005-11-03 | Комбинации антагонистов никотинового ацетилхолинового альфа-7-рецептора |
CNA2005800353479A CN101039670A (zh) | 2004-11-05 | 2005-11-03 | 烟碱性乙酰胆碱α7受体激动剂的组合 |
MX2007005428A MX2007005428A (es) | 2004-11-05 | 2005-11-03 | Combinaciones de agonistas del receptor nicotinico alfa 7 y de la acetilcolina. |
KR1020137002723A KR20130024974A (ko) | 2004-11-05 | 2005-11-03 | 니코틴성 아세틸콜린 알파 7 수용체 아고니스트의 조합물 |
EP05799805A EP1809285A1 (en) | 2004-11-05 | 2005-11-03 | Combinations of nicotinic acetylcholine alpha 7 receptor agonists |
AU2005300691A AU2005300691A1 (en) | 2004-11-05 | 2005-11-03 | Combinations of nicotinic acetylcholine alpha 7 receptor agonists |
BRPI0517647-6A BRPI0517647A (pt) | 2004-11-05 | 2005-11-03 | combinações de agonistas do receptor nicotìnico alfa 7 de acetilcolina |
KR1020077010199A KR101302898B1 (ko) | 2004-11-05 | 2005-11-03 | 니코틴성 아세틸콜린 알파 7 수용체 아고니스트의 조합물 |
JP2007538364A JP2008518896A (ja) | 2004-11-05 | 2005-11-03 | ニコチン性アセチルコリンα7受容体アンタゴニストの組合せ剤 |
PCT/EP2005/011787 WO2006048294A1 (en) | 2004-11-05 | 2005-11-03 | Combinations of nicotinic acetylcholine alpha 7 receptor agonists |
US12/690,905 US20100125063A1 (en) | 2004-11-05 | 2010-01-20 | Combinations of nicotinic acetylcholine alpha 7 receptor agonists |
JP2012220444A JP2012255039A (ja) | 2004-11-05 | 2012-10-02 | ニコチン性アセチルコリンα7受容体アゴニストの組合せ剤 |
JP2014124396A JP2014196328A (ja) | 2004-11-05 | 2014-06-17 | ニコチン性アセチルコリンα7受容体アゴニストの組合せ剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0424564A GB0424564D0 (en) | 2004-11-05 | 2004-11-05 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0424564D0 true GB0424564D0 (en) | 2004-12-08 |
Family
ID=33523294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0424564A Ceased GB0424564D0 (en) | 2004-11-05 | 2004-11-05 | Organic compounds |
Country Status (12)
Country | Link |
---|---|
US (2) | US20080306081A1 (ja) |
EP (3) | EP1809285A1 (ja) |
JP (3) | JP2008518896A (ja) |
KR (2) | KR101302898B1 (ja) |
CN (1) | CN101039670A (ja) |
AU (1) | AU2005300691A1 (ja) |
BR (1) | BRPI0517647A (ja) |
CA (1) | CA2582436C (ja) |
GB (1) | GB0424564D0 (ja) |
MX (1) | MX2007005428A (ja) |
RU (1) | RU2007120690A (ja) |
WO (1) | WO2006048294A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
PE20060437A1 (es) | 2004-06-18 | 2006-06-08 | Novartis Ag | COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR |
GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
EP1863485A2 (en) * | 2005-03-18 | 2007-12-12 | Abbott Laboratories | Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions |
EP2258358A3 (en) * | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
GB0521508D0 (en) | 2005-10-21 | 2005-11-30 | Novartis Ag | Organic compounds |
GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
PE20091564A1 (es) * | 2008-02-29 | 2009-11-04 | Biolab Sanus Farmaceutica Ltda | Composicion farmaceutica de un derivado racetam y carnitina |
TWI558398B (zh) * | 2009-09-22 | 2016-11-21 | 諾華公司 | 菸鹼乙醯膽鹼受體α7活化劑之用途 |
BR112013001939A2 (pt) * | 2010-07-26 | 2017-07-11 | Envivo Pharmaceuticals Inc | tratamento de distúrbios cognitivos com determinados agonistas receptores de ácido alfa-7-nicotínico em combinação com inibidres de acetilcolinesterase |
EP2675893B1 (en) * | 2011-02-18 | 2019-01-09 | The Scripps Research Institute | Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate |
MX2013010698A (es) * | 2011-03-18 | 2014-02-17 | Novartis Ag | Combinaciones de activadores del receptor de acetil-colina nicotinico alfa-7 y antagonistas del receptor de glutamato metabotropico 5 (mglur5) para usarse en la discinesia inducida por dopamina en la enfermedad de parkinson. |
US20230381169A1 (en) * | 2020-11-25 | 2023-11-30 | Vanda Pharmaceuticals Inc. | Treatment of public speaking anxiety with an alpha-7 nicotinic acetylcholine receptor agonist |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB261309A (en) | 1926-07-23 | 1926-11-18 | Oswald Pfeiffer | Improvements in collapsible grids |
GB281309A (en) | 1926-11-27 | 1928-03-29 | Inventia Patent Verwert Ges | Improvements in or relating to brushing machines having replaceable brush members |
US3310553A (en) | 1962-09-25 | 1967-03-21 | Pfizer & Co C | Alkylated thioxathenesulfonamides |
US3539573A (en) * | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
US5006528A (en) | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
SE9600683D0 (sv) * | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
SE9903760D0 (sv) | 1999-10-18 | 1999-10-18 | Astra Ab | New compounds |
SE0000540D0 (sv) | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
GB0010955D0 (en) * | 2000-05-05 | 2000-06-28 | Novartis Ag | Organic compounds |
PE20021019A1 (es) * | 2001-04-19 | 2002-11-13 | Upjohn Co | Grupos azabiciclicos sustituidos |
AR036040A1 (es) * | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
MXPA04000779A (es) * | 2001-08-24 | 2004-04-20 | Pharmacia & Up John Company | 7-aza[2.2.1]bicicloheptanos sustituidos con arilo para el tratamiento de enfermedades. |
MXPA04004464A (es) * | 2001-11-08 | 2004-08-11 | Upjohn Co | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. |
US7176198B2 (en) * | 2002-08-01 | 2007-02-13 | Pfizer Inc. | 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
US20050245567A1 (en) | 2002-08-14 | 2005-11-03 | Dan Peters | Novel quinuclidine derivatives and their use |
GB0220581D0 (en) * | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
WO2004039321A2 (en) * | 2002-10-29 | 2004-05-13 | Miicro, Inc. | Combinative nicotinic/d1 agonism therapy for the treatment of alzheimer’s disease |
EP1572300A1 (en) * | 2002-12-11 | 2005-09-14 | Pharmacia & Upjohn Company LLC | Combination for the treatment of adhd |
FR2931677B1 (fr) * | 2008-06-02 | 2010-08-20 | Sanofi Aventis | Association d'un agoniste partiel des recepteurs nicotiniques et d'un inhibiteur d'acetylcholinesterase, composition la contenant et son utilisation dans le traitement des troubles cognitifs |
US8514784B2 (en) | 2008-08-27 | 2013-08-20 | Zte Corporation | Method for processing downlink signal in sector portion and base station thereof |
US10066977B2 (en) | 2009-01-26 | 2018-09-04 | Canon U.S. Life Sciences, Inc. | Microfluidic flow monitoring |
-
2004
- 2004-11-05 GB GB0424564A patent/GB0424564D0/en not_active Ceased
-
2005
- 2005-11-03 KR KR1020077010199A patent/KR101302898B1/ko not_active IP Right Cessation
- 2005-11-03 RU RU2007120690/15A patent/RU2007120690A/ru not_active Application Discontinuation
- 2005-11-03 KR KR1020137002723A patent/KR20130024974A/ko not_active Application Discontinuation
- 2005-11-03 CN CNA2005800353479A patent/CN101039670A/zh active Pending
- 2005-11-03 US US11/718,668 patent/US20080306081A1/en not_active Abandoned
- 2005-11-03 EP EP05799805A patent/EP1809285A1/en not_active Withdrawn
- 2005-11-03 CA CA2582436A patent/CA2582436C/en not_active Expired - Fee Related
- 2005-11-03 WO PCT/EP2005/011787 patent/WO2006048294A1/en active Application Filing
- 2005-11-03 BR BRPI0517647-6A patent/BRPI0517647A/pt not_active IP Right Cessation
- 2005-11-03 EP EP09167139A patent/EP2135609A1/en not_active Withdrawn
- 2005-11-03 MX MX2007005428A patent/MX2007005428A/es active IP Right Grant
- 2005-11-03 JP JP2007538364A patent/JP2008518896A/ja not_active Withdrawn
- 2005-11-03 EP EP20110155176 patent/EP2332537A1/en not_active Withdrawn
- 2005-11-03 AU AU2005300691A patent/AU2005300691A1/en not_active Abandoned
-
2010
- 2010-01-20 US US12/690,905 patent/US20100125063A1/en not_active Abandoned
-
2012
- 2012-10-02 JP JP2012220444A patent/JP2012255039A/ja active Pending
-
2014
- 2014-06-17 JP JP2014124396A patent/JP2014196328A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CN101039670A (zh) | 2007-09-19 |
EP2135609A1 (en) | 2009-12-23 |
EP2332537A1 (en) | 2011-06-15 |
KR101302898B1 (ko) | 2013-09-06 |
KR20130024974A (ko) | 2013-03-08 |
JP2012255039A (ja) | 2012-12-27 |
KR20070073881A (ko) | 2007-07-10 |
BRPI0517647A (pt) | 2008-10-14 |
MX2007005428A (es) | 2007-05-18 |
JP2008518896A (ja) | 2008-06-05 |
US20100125063A1 (en) | 2010-05-20 |
JP2014196328A (ja) | 2014-10-16 |
EP1809285A1 (en) | 2007-07-25 |
WO2006048294A1 (en) | 2006-05-11 |
US20080306081A1 (en) | 2008-12-11 |
RU2007120690A (ru) | 2008-12-10 |
AU2005300691A1 (en) | 2006-05-11 |
CA2582436A1 (en) | 2006-05-11 |
CA2582436C (en) | 2016-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0410712D0 (en) | Organic compounds | |
GB0409921D0 (en) | Organic compounds | |
GB0403038D0 (en) | Organic compounds | |
GB0407723D0 (en) | Organic compounds | |
GB0401334D0 (en) | Organic compounds | |
GB0405289D0 (en) | Organic compounds | |
GB0402797D0 (en) | Organic compounds | |
GB0404434D0 (en) | Organic compounds | |
GB0408078D0 (en) | Organic compounds | |
GB0424564D0 (en) | Organic compounds | |
GB0400781D0 (en) | Organic compounds | |
GB0406515D0 (en) | Organic compounds | |
GB0403115D0 (en) | Organic compounds | |
GB0403254D0 (en) | Organic compounds | |
GB0405723D0 (en) | Organic compounds | |
GB0409236D0 (en) | Organic compounds | |
GB0406240D0 (en) | Organic compounds | |
GB0405898D0 (en) | Organic compounds | |
GB0407607D0 (en) | Organic compounds | |
GB0405034D0 (en) | Organic compounds | |
GB0406241D0 (en) | Organic compounds | |
GB0401090D0 (en) | Organic compounds | |
GB0400179D0 (en) | Organic compounds | |
GB0406381D0 (en) | Organic compounds | |
GB0401761D0 (en) | Organic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |